MarketInOut Stock Screener Log In | Sign Up

Beryl Drugs Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Beryl Drugs Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization126.79 mln
Float3.06 mln

EPS

1.55
Moderate

P / E

16.52
Moderately valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.13
Reliable

Relative Strength

95 / 100
Top performer

Debt / Equity

0.25
Very low leverage

Business Description

Founded in 1993 and headquartered in Indore, India, Beryl Drugs Limited produces and sells a wide range of medicines across both human and animal health markets. Its product lineup includes branded and generic drugs, intravenous fluids, injectable solutions, and eye and ear drops. The company also takes on manufacturing work for other businesses and conducts ongoing research to develop new treatments. Beryl Drugs sells its products within India and to customers abroad.

Key Fundamentals

EPS1.55
P/E16.52
ROE6.50
RPS37.11
ROIC6.12
ROA3.86
Interest Cover3.58
EBITDA, mln25.22
EV / EBITDA5.84
EV / EBIT13.47
Revenue, mln220
EV / Revenue0.67

Quote Details

Last 25.60
Change 0.6 (2.4%)
Open 27.00
Volume 2,166
Turnover 55,450
Average Volume 2,046.76

Financial Ratios

Pre-Tax Profit Margin4
Leverage Ratio1.51
Current Ratio1.52
Price / Book1.22
Price / Tangible Book1.22
Debt / Equity0.25
Price / Sales0.55
PEG Ratio1.10

Financial Strength

Altman Z-Score3.84
Piotroski F-Score 5 / 9
Beneish M-Score-3.13
Price to Lynch Fair Value1.18
Price to Graham Number1.24
Shiller PE Ratio20.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.69% 73 / 100   
1 Month -0.66% 74 / 100   
2 Months 16.68% 87 / 100   
6 Months 16.36% 81 / 100   
1 Year 15.32% 82 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog